1. All Products
  2. DORA - Oral drugs
  3. ETHAMBUTOL hydrochloride (E), eq. 400 mg base, tab. blister
Public Pricelist

ETHAMBUTOL hydrochloride (E), eq. 400 mg base, tab. blister

https://medicalguidelines.msf.org/en/node/401
https://unicat.msf.org/cat/product/12024
STD DORAETHA4T1

Valid Article

Former Code(s): DORAETHA4T-
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AK02
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ETHAMBUTOL (E)

Therapeutic Action

Antituberculosis bacteriostatic

Indications

Drug-Resistant tuberculosis (DR-TB), in combination with other TB medicines

Drug-Sensitive tuberculosis (DS-TB)

Instructions for use

The 50 and 100 mg dispersible tablets are intended for paediatric use. To be dispersed in 10 ml water.

The dispersible tablet should replaces the normal 100mg tablet (second choice).

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per tablet, not per blister.

When ethambutol is used in association with other TB medicines, fixed-dose combinations (FDC) are available:

  • E 275mg / H 75mg / Z 400mg / R 150mg, tab., blister
  • E 275mg / H 75mg / R 150mg, tab., blister

Precautions for Use

Do not administer to patients with severe renal impairment or pre-existing optic neuritis (e.g. diabetic retinopathy).

Storage

Below 25ºC ‐ Protect from sunlight ‐ Protect from humidity